{"address1": "80 Guest Street", "address2": "5th Floor", "city": "Boston", "state": "MA", "zip": "02135", "country": "United States", "phone": "617 500 8864", "website": "https://www.aurabiosciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmette\u0096gu\u00e9rin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 106, "companyOfficers": [{"maxAge": 1, "name": "Dr. Elisabet  de los Pinos Ph.D.", "age": 50, "title": "Founder, CEO, President & Director", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 895160, "exercisedValue": 0, "unexercisedValue": 4928582}, {"maxAge": 1, "name": "Ms. Amy  Elazzouzi", "age": 51, "title": "Interim Principal Financial Officer & Interim Principal Accounting Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark  Plavsic D.V.M., Ph.D.", "age": 63, "title": "Chief Technology Officer", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Conor  Kilroy", "age": 42, "title": "General Counsel & Secretary", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Patrick  Nealon", "title": "Senior Vice President of Clinical Development Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anthony  Daniels M.D.", "title": "VP & Therapeutic Area of Head Ocular Oncology", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Richard  Mountfield Ph.D.", "title": "Senior Vice President of Regulatory Affairs & Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jill J. Hopkins M.D.", "age": 59, "title": "Chief Medical Officer & President of Research and Development", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sabine  Brookman-May", "title": "Senior VP & Therapeutic Area Head of Urologic Oncology", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 5, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.86, "open": 5.81, "dayLow": 5.53, "dayHigh": 5.85, "regularMarketPreviousClose": 5.86, "regularMarketOpen": 5.81, "regularMarketDayLow": 5.53, "regularMarketDayHigh": 5.85, "payoutRatio": 0.0, "beta": 0.3, "forwardPE": -2.7931035, "volume": 436762, "regularMarketVolume": 436762, "averageVolume": 230676, "averageVolume10days": 639230, "averageDailyVolume10Day": 639230, "bid": 5.65, "ask": 5.78, "bidSize": 4, "askSize": 4, "marketCap": 284777440, "fiftyTwoWeekLow": 5.53, "fiftyTwoWeekHigh": 12.378, "fiftyDayAverage": 7.4568, "twoHundredDayAverage": 8.448425, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 152452512, "profitMargins": 0.0, "floatShares": 32012107, "sharesOutstanding": 50225300, "sharesShort": 1194732, "sharesShortPriorMonth": 1293150, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0239, "heldPercentInsiders": 0.03078, "heldPercentInstitutions": 0.82351995, "shortRatio": 7.2, "shortPercentOfFloat": 0.0324, "impliedSharesOutstanding": 54339300, "bookValue": 3.04, "priceToBook": 1.8651316, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -86919000, "trailingEps": -1.75, "forwardEps": -2.03, "enterpriseToEbitda": -1.607, "52WeekChange": -0.22328764, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 5.67, "targetHighPrice": 25.0, "targetLowPrice": 19.0, "targetMeanPrice": 22.0, "targetMedianPrice": 22.5, "recommendationMean": 1.42857, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 151094000, "totalCashPerShare": 3.008, "ebitda": -94893000, "totalDebt": 18769000, "quickRatio": 10.132, "currentRatio": 10.771, "debtToEquity": 12.35, "returnOnAssets": -0.27457002, "returnOnEquity": -0.46011, "freeCashflow": -50171500, "operatingCashflow": -79805000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "AURA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Aura Biosciences, Inc.", "corporateActions": [], "preMarketTime": 1743582159, "regularMarketTime": 1743537602, "exchange": "NGM", "messageBoardId": "finmb_100249028", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "Aura Biosciences, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1635514200000, "preMarketChange": -0.55999994, "preMarketChangePercent": -9.876542, "preMarketPrice": 5.11, "regularMarketChange": -0.19000006, "regularMarketDayRange": "5.53 - 5.85", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 230676, "fiftyTwoWeekLowChange": 0.13999987, "fiftyTwoWeekLowChangePercent": 0.02531643, "fiftyTwoWeekRange": "5.53 - 12.378", "fiftyTwoWeekHighChange": -6.708, "fiftyTwoWeekHighChangePercent": -0.54192924, "fiftyTwoWeekChangePercent": -22.328764, "earningsTimestamp": 1742846460, "earningsTimestampStart": 1746793800, "earningsTimestampEnd": 1748089800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.75, "epsForward": -2.03, "fiftyDayAverageChange": -1.7867999, "fiftyDayAverageChangePercent": -0.2396202, "twoHundredDayAverageChange": -2.7784252, "twoHundredDayAverageChangePercent": -0.32886901, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-29", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -3.2423217, "regularMarketPrice": 5.67, "marketState": "PRE", "displayName": "Aura Biosciences", "trailingPegRatio": null}